HDFC Bank stock to be in focus after Mehta family's FIR against CEO over Lilavati Trust allegations

HDFC Bank's stock is in focus following the filing of an FIR against its MD and CEO, Sashidhar Jagdishan, by the Mehta family through the Lilavati Kirtilal Medical Trust. The FIR alleges involvement in a series of financial frauds. HDFC Bank has strongly refuted the allegations, stating they are baseless, malicious, and a retaliatory action by a recalcitrant defaulter. The bank clarified that the complaint stems from a long-standing loan default by the Mehta family dating back to 1995, with outstanding dues of approximately Rs 65.22 crore. According to the bank, the Mehta family has initiated multiple unsuccessful legal actions to thwart the recovery proceedings. This development introduces a level of uncertainty and could impact investor sentiment towards the bank's stock in the short term, despite the bank's firm denial and assertion that it is an attempt to malign its reputation.